Emerging tier · Weight Management
Sermorelin for Weight Management
Clinical DataLegal to Compound
A GHRH analog that stimulates natural growth hormone release from the pituitary gland.
Medical Disclaimer
This page is for educational purposes only. It is not a treatment protocol or prescription. All compounds require medical supervision. Consult a qualified healthcare provider before use.
Why Sermorelin for Weight Management
Role in Protocol
GH-mediated body composition improvement
Evidence Note
A GHRH analog that stimulates endogenous GH release. Some clinical data suggest favorable shifts in body composition (reduced fat mass, preserved lean mass), though evidence is less robust than for GLP-1 RAs.
Dosing Context
GH Optimization (Clinic Protocol)
Dose
200–500 mcg
Frequency
daily
Duration
3-6 months for full benefit
Often Used Alongside
Key Safety Notes
Active cancer or history of cancer
GH and IGF-1 are growth factors that may promote tumour growth.
Active pituitary tumours
GHRH stimulation may exacerbate pituitary pathology.
Full Sermorelin Profile →
Full Weight Management Protocol →